Thyroglobulin (Tg) measurement is an essential diagnostic element of the follow‐up and management of patients with differentiated thyroid cancer (DTC), as the 660 kDa glycoprotein is exclusively produced by benign or well‐differentiated malignant thyroid cells. This evidence concerns the gene TG and differentiated thyroid carcinoma.